Work

Supplementary Data from Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figures S1-S9; Supplementary Tables S1-S3.

DOI: 10.1158/1078-0432.22442678

Authors: Caroline H. Diep, Ruben M. Munoz, Ashish Choudhary, Daniel D. Von Hoff, Haiyong Han

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362392879

Cites:

Cited by:

Related to: 10